A Single-Center, Double-Masked, Randomized, Vehicle Controlled Study to Evaluate the Safety and Efficacy of Testosterone 0.03% Ophthalmic Solution Compared to Vehicle for the Treatment of Meibomian Gland Dysfunction

This study is enrolling participants by invitation only.

Study NCT00755183 Information provided by ORA, Inc.

First Received: September 17, 2008 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)